On the eve of World Tuberculosis Day, Health Minister J.P. Nadda launched Bedaquiline — new drug for Drug Resistant TB — as part of the national programme.-The drug will be introduced in 104 districts across five States.
-The new class of drug is a diarylquinoline that specifically targets Mycobacterial ATP synthase, an enzyme essential for the supply of energy to Mycobacterium tuberculosis and most other mycobacteria.
-Bedaquiline is being introduced at six tertiary care centres across India. These sites have advanced facilities for laboratory testing and intensive care for patients.
-Bedaquiline will be given to multi-drug resistant TB patients with resistance to either all fluoroquinolone and/or all second line injectables and extensive drug resistant TB.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.